Ubs Asset Management Americas Inc Eli Lilly & CO Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 6,115,504 shares of LLY stock, worth $4.76 Billion. This represents 1.42% of its overall portfolio holdings.

Number of Shares

6,115,504

Previous 5,957,763 2.65%

Holding current value

$4.76 Billion

Previous $5.39 Billion 0.44%

% of portfolio

1.42%

Previous 1.56%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $122 Million - $151 Million	157,741 Added 2.65%	6,115,504 $5.42 Billion
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $970 Million - $1.22 Billion	1,337,908 Added 28.96%	5,957,763 $5.39 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $72 Million - $96.3 Million	121,525 Added 2.7%	4,619,855 $3.59 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $65.9 Million - $77.7 Million	125,548 Added 2.87%	4,498,330 $2.62 Billion
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $108 Million - $149 Million	-247,830 Reduced 5.36%	4,372,782 $2.35 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $106 Million - $124 Million	340,500 Added 7.96%	4,620,612 $1.59 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $94.7 Million - $110 Million	294,554 Added 7.39%	4,280,112 $1.57 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $59.7 Million - $68.1 Million	-201,487 Reduced 4.81%	3,985,558 $1.29 Billion
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $60.6 Million - $71.2 Million	-217,589 Reduced 4.94%	4,187,045 $1.36 Billion
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $8.39 Million - $10.4 Million	35,764 Added 0.82%	4,404,634 $1.26 Billion
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $31 Million - $38.4 Million	-137,698 Reduced 3.06%	4,368,870 $1.21 Billion
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $33.8 Million - $41.7 Million	-152,747 Reduced 3.28%	4,506,568 $1.04 Billion
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $49.7 Million - $64.3 Million	275,432 Added 6.28%	4,659,315 $1.07 Billion
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $19.2 Million - $24.9 Million	117,056 Added 2.74%	4,383,883 $819 Million
Q4 2020 Mar 01, 2021	SELL	$130.46 - $172.63 $21 Million - $27.8 Million	-161,306 Reduced 3.64%	4,266,827 $720 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $12.2 Million - $14.1 Million	83,647 Added 1.93%	4,428,133 $655 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $21.5 Million - $25.9 Million	-157,806 Reduced 3.51%	4,344,486 $713 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $25 Million - $30.9 Million	210,040 Added 4.89%	4,502,292 $625 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $4.52 Million - $5.59 Million	42,232 Added 0.99%	4,292,252 $564 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $8.86 Million - $9.64 Million	82,971 Added 1.99%	4,250,020 $475 Million
Q2 2019 Aug 15, 2019	BUY	$110.79 - $129.32 $21.9 Million - $25.5 Million	197,542 Added 4.98%	4,167,049 $0
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $113 Million - $133 Million	-1,012,937 Reduced 20.33%	3,969,507 $0
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $27.5 Million - $30.8 Million	259,244 Added 5.49%	4,982,444 $577 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $10.6 Million - $13.3 Million	-123,864 Reduced 2.56%	4,723,200 $0
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $6.06 Million - $6.96 Million	80,091 Added 1.68%	4,847,064 $0
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $139 Million - $164 Million	-1,869,413 Reduced 28.17%	4,766,973 $0
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $9.46 Million - $10.2 Million	115,499 Added 1.77%	6,636,386 $0
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $503 Million - $558 Million	6,520,887	6,520,887 $0

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Eli Lilly & CO Transaction History